The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6% among adults aged 50 years and older in 2017 to 2018.
Authors of the review discuss primary considerations and areas for future research regarding bisphosphonate drug holiday duration in patients with osteoporosis.
In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19 vaccination.
ASBMR, AACE, Endocrine Society, ECTS, IOF, and NOF developed guidance on COVID-19 vaccination and osteoporosis management.
Study authors identified whether the hemoglobin A1c threshold level where reduction in bone turnover begins.
The Sydney AFF Score is a tool to help differentiate atypical from typical femur fractures in women, independent of bisphosphonate use.
Patients who have had bariatric surgery are at high risk of fractures due to bone loss, but now researchers say that resistance, high-impact and balance exercises can protect these patients from bone mineral density loss.
The objective of this study was to analyze the risk of incident vertebral and nonvertebral fracture in men with DISH.
Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.
Researchers sought to identify potential vertebral fracture and bone loss risk factors after discontinuation of denosumab therapy and initiation of other therapy.
Researchers sought to investigate the impact of vitamin D-specific variables on indices of bone and mineral metabolism in older adults.